From left, Senator Debbie Stabenow; Pam Marrone, CEO, Marrone Bio Innovations; Jennifer Carpio-Zeller, Mayor, Bangor.
BANGOR, US: Marrone Bio Innovations Inc (MBI), a leading global provider of natural pest management products for the agricultural and water treatment markets, announced the groundbreaking of the Marrone Michigan manufacturing facility in Bangor, Michigan. As a bio-based manufacturer, MBI is precisely the type of company that Senator Stabenow is looking to bring to Michigan.
MBI’s acquisition of the Bangor facility marks the expansion of its manufacturing strategy to accommodate long-term growth and is expected to bring 50 new jobs to the region over the next few years. The 11-acre, 11,000-square-foot manufacturing site is a former biodiesel manufacturing plant that MBI plans to repurpose to produce natural pest management products, or biopesticides, for the agriculture and water treatment markets beginning in early 2013.
“We expect that having a US based facility with access to a highly skilled workforce in Michigan will allow us to maintain an exemplary level of quality control as we manufacture our products. This is extremely important as we seek to commercialize additional products, grow our production capacity and serve our worldwide customers and distribution partners,” said Pam Marrone, CEO, MBI.
The Bangor facility will complement MBI’s existing third party manufacturing relationships. Initially, MBI plans to manufacture two of its most recently introduced products at the new site: Grandevo, a broadspectrum bioinsecticide for controlling insects and mites, and Zequanox, the first naturally derived product for the control of invasive zebra and quagga mussels. MBI has several other early stage products that it plans to manufacture in Bangor once approved by the EPA.
© WOC News